SCHEMBL1404990

SCHEMBL1404990

CC(=O)C=Cc1cccc(C)c1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IAPP P10997 5/20 0.71
LMNA P02545 2/20 0.59
MAPT P10636 2/20 0.59
PTGER1 P34995 1/20 0.55
PTGER4 P35408 1/20 0.55
PTGER3 P43115 1/20 0.55
PTGER2 P43116 1/20 0.55
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.46
GLA P06280 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TRPA1 O75762 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1404989 1.00 IAPP (0.71) IAPPLMNAMAPTPTGER1PTGER4
SCHEMBL9658945 0.85 PTGER3 (0.71) IAPPMAPTPTGER1PTGER4PTGER3
SCHEMBL11830587 0.85 PTGER3 (0.71) IAPPMAPTPTGER1PTGER4PTGER3
SCHEMBL26046362 0.83 IAPP (1.00) IAPPLMNAMAPTKDM4EGLA
SCHEMBL7177478 0.83 IAPP (1.00) IAPPLMNAMAPTKDM4EGLA
SCHEMBL2834883 0.82 MAPT (0.66) IAPPLMNAMAPTKDM4EALDH1A1
SCHEMBL31422587 0.82 MAPT (0.66) IAPPLMNAMAPTKDM4EALDH1A1
SCHEMBL14279409 0.82 MAPT (0.66) IAPPLMNAMAPTKDM4EALDH1A1
SCHEMBL7899013 0.82 MAPT (0.66) IAPPLMNAMAPTKDM4EALDH1A1
SCHEMBL13177051 0.82 PTGER1 (0.56) IAPPLMNAMAPTPTGER1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079747-B1 HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS PFIZER LTD (GB) 2011-03-09 EP disclosed
EP-2079747-A1 HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS Pfizer Limited (GB) 2009-07-22 EP disclosed
US-20080161288-A1 COMPOUNDS PFIZER INC. 2008-07-03 US disclosed
WO-2008044127-A1 HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS PFIZER LIMITED (GB) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161288-A1 COMPOUNDS ADRB2, ADRB1, ADRA2C IAPP 1485/4885LMNA 1543/4885MAPT 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.